Q36-21282-50008
3 vaccinations
3 coded responses
25 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 501 / IA
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Moderna
-
2021-01-13
Survey response — day 0, dose 1MedDRA: Immediate post-injection reaction, Paraesthesia oral — Feeling: GoodFree text: Lip tingling- did NOT swell- within a few minutes of receiving vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-14
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-29
- 2021-02-03
-
2021-02-11
Dose 2 — Moderna
- 2021-02-13
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-03-04
- 2021-03-20
- 2021-03-25
- 2021-05-13
- 2021-08-12
-
2021-12-06
Dose 3 — Moderna
- 2021-12-18
-
2021-12-20
Survey response — day 14, dose 3MedDRA: Pruritus, Urticaria — Feeling: FairFree text: Hives and itchingMedDRA releases: 2024-11 · check-in free text available
-
2021-12-27
Survey response — day 21, dose 3MedDRA: Rash — Feeling: FairFree text: RashMedDRA releases: 2024-11 · check-in free text available
- 2022-01-05
- 2022-01-10
- 2022-01-17
- 2022-03-07
- 2022-06-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Moderna | |
| 2 | 2021-02-11 | Moderna | |
| 3 | 2021-12-06 | Moderna | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Lip tingling- did NOT swell- within a few minutes of receiving vaccine
Release 10 — day 14, dose 3
Symptoms: Hives and itching
Release 10 — day 21, dose 3
Symptoms: Rash
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pruritus | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Paraesthesia oral | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release